Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SP4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZFP3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZMAT3 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | ZNF24 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ARHGEF7 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | PGBD5 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ZBTB8B | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | PAXBP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | C21orf58 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | HRH3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |